Form 4: Doximity Director Kevin Spain Receives RSU Grant

Doximity Director Kevin Spain was granted 3,221 restricted stock units as part of the company's non-employee director compensation policy.

Summary

• Director Kevin Spain acquired 3,221 restricted stock units (RSUs) of Doximity, Inc. Class A Common Stock on August 28, 2025.
• These RSUs were granted under the Issuer's non-employee director compensation policy, with a transaction price of $0.
• The RSUs are scheduled to vest in full on the earlier of the first anniversary of the grant date or the Issuer's next annual meeting of stockholders, subject to continued service.
• Following this transaction, Kevin Spain directly holds 9,581 shares (including the new RSUs and previously vested shares) and indirectly holds 244,607 shares via The Kevin Spain Family Trust and 387,500 shares via Emergence Capital Opportunity I, L.P.
• Kevin Spain disclaims Section 16 beneficial ownership for most of these shares, except to the extent of his pecuniary interest therein.

Sentiment

Score: 6

Explanation: The grant of restricted stock units to a director is a standard compensation practice, indicating continued alignment of interests. It's a neutral to slightly positive event as it shows commitment from the director and is part of normal operations.

Positives

• The grant of 3,221 restricted stock units to Director Kevin Spain aligns his interests with shareholders, promoting long-term value creation.
• The equity-based compensation structure encourages continued service and commitment from the director through its vesting conditions.

Future Outlook

The grant of 3,221 restricted stock units on August 28, 2025, is subject to future vesting conditions. The RSUs are expected to vest in full on the earlier of August 28, 2026, or the Issuer's next annual meeting of stockholders, contingent on Kevin Spain's continued service as a director.

Industry Context

Non-employee director compensation through equity grants like restricted stock units is a standard practice across many industries, including healthcare technology, to align director incentives with long-term company performance and shareholder value.

Comparison to Industry Standards

• The grant of restricted stock units (RSUs) as part of non-employee director compensation is a common practice, comparable to companies like Teladoc Health (TDOC) or Veeva Systems (VEEV) which also utilize equity-based compensation to attract and retain qualified independent directors.
• The vesting schedule, tied to continued service and annual meetings, is standard for such grants, ensuring directors remain engaged over a defined period.

Corporate Governance

Related Party Transactions

• Kevin Spain's indirect holdings through The Kevin Spain Family Trust Dated 11/14/22.
• Kevin Spain's indirect holdings through Emergence Capital Opportunity I, L.P., where he is a member of a general partner entity (Emergence Equity Partners VI, L.P., which is the sole general partner of Emergence Capital Opportunity I, L.P.).
• Contractual obligation for Kevin Spain to transfer and/or remit the proceeds of any sale of shares issued upon vesting of RSUs to Emergence Equity Partners II, L.P.

Stakeholder Impact

• Shareholders: Interests are further aligned with the director through equity compensation, potentially fostering long-term value creation.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• The granted RSUs will vest in full on the earlier of August 28, 2026 (first anniversary of grant) or Doximity's next annual meeting of stockholders.
• Kevin Spain's continued service as a director is required for the RSUs to vest.

Key Dates

Recommendation

This Form 4 filing details a routine grant of restricted stock units to a non-employee director as part of their compensation. While it indicates continued alignment of the director's interests with the company's long-term performance, it does not present new fundamental information that would warrant a change in an investment thesis. It is a standard disclosure of an insider transaction, not a catalyst for significant price movement.

Keywords

Doximity, DOCS, Kevin Spain, Restricted Stock Units, RSU, Director Compensation, Insider Transaction, SEC Form 4, Equity Grant, Beneficial Ownership